tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Autolus Therapeutics PLC

AUTL
Add to Watchlist
1.490USD
-0.040-2.61%
Close 07-31 16:00（ET）Quotes delayed by 15 min
396.57MMarket Cap
LossP/E TTM

Autolus Therapeutics PLC

1.490
-0.040-2.61%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

AUTL Financials

See Autolus Therapeutics PLC's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Autolus Therapeutics PLC Earnings Date

Latest Release
May 14, 2026
EPS / Forecast
-0.27/-0.26
Revenue / Forecast
26.22M/26.16M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
75.39M
644.94%
EPS(YoY)
-1.08
-24.93%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-2.04%-0.27
-227.30%-0.34
3.65%-0.30
17.81%-0.18
-11.17%-0.26
76.61%-0.10
-17.08%-0.31
16.39%-0.22
-3.55%-0.24
-75.80%-0.44
---0.26
---0.26
---0.23
---0.25
---1.34
----
----
----
----
----
Revenue
191.89%26.22M
83655.17%24.29M
--21.19M
--20.92M
-10.99%8.98M
--29.00K
-100.00%0.00
----
681.04%10.09M
-100.00%0.00
-82.86%406.00K
----
678.31%1.29M
2025.00%3.83M
903.81%2.37M
-100.00%0.00
-38.29%166.00K
-55.45%180.00K
-65.29%236.00K
461.43%1.65M
Net Profit
-2.05%-71.60M
-227.22%-90.33M
3.63%-79.12M
17.77%-47.92M
-33.16%-70.16M
64.23%-27.61M
-79.05%-82.09M
-27.92%-58.27M
-32.35%-52.69M
-186.34%-77.17M
-7.21%-45.85M
-8.31%-45.55M
-7.42%-39.81M
35.32%-26.95M
-25.82%-42.77M
-26.79%-42.06M
-11.41%-37.06M
2.79%-41.67M
8.91%-33.99M
-3.52%-33.17M
Net Margin
65.04%-273.09%
99.61%-371.90%
---373.30%
---229.02%
-49.60%-781.13%
---95193.10%
----
----
83.05%-522.15%
----
---11292.86%
----
---3081.35%
---704.60%
---4808.21%
----
----
----
----
----
Gross Margin
106.30%6.29%
99.99%-4.29%
---35.15%
---16.83%
-199.86%-99.86%
---39165.52%
----
----
0.00%100.00%
----
--100.00%
----
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
54.92%52.61%
46.78%45.87%
30.23%39.18%
21.36%33.93%
33.97%33.96%
-31.36%31.25%
-13.22%30.08%
-7.12%27.96%
-10.87%25.35%
77.29%45.53%
--34.67%
--30.10%
--28.44%
--25.68%
--19.88%
----
----
----
----
----
Income Statement
Revenue
191.89%26.22M
83655.17%24.29M
--21.19M
--20.92M
-10.99%8.98M
--29.00K
-100.00%0.00
----
681.04%10.09M
-100.00%0.00
-82.86%406.00K
----
678.31%1.29M
2025.00%3.83M
903.81%2.37M
-100.00%0.00
-38.29%166.00K
-55.45%180.00K
-65.29%236.00K
461.43%1.65M
Operating profit
8.77%-59.51M
4.48%-72.47M
-5.87%-71.62M
-4.62%-61.22M
-68.32%-65.24M
-85.55%-75.86M
-59.10%-67.65M
-31.93%-58.52M
-9.54%-38.76M
-267.18%-40.89M
2.23%-42.52M
4.58%-44.35M
15.33%-35.38M
51.79%-11.13M
-7.78%-43.49M
-23.22%-46.48M
-6.59%-41.78M
51.20%-23.10M
5.51%-40.35M
4.60%-37.72M
Net Profit
-2.05%-71.60M
-227.22%-90.33M
3.63%-79.12M
17.77%-47.92M
-33.16%-70.16M
64.23%-27.61M
-79.05%-82.09M
-27.92%-58.27M
-32.35%-52.69M
-186.34%-77.17M
-7.21%-45.85M
-8.31%-45.55M
-7.42%-39.81M
35.32%-26.95M
-25.82%-42.77M
-26.79%-42.06M
-11.41%-37.06M
2.79%-41.67M
8.91%-33.99M
-3.52%-33.17M
Balance Sheet
Current assets
-40.10%368.83M
-34.05%435.92M
-28.34%514.58M
-24.30%574.25M
-23.44%615.77M
140.07%660.93M
132.87%718.11M
113.47%758.60M
104.20%804.30M
-35.34%275.30M
45.25%308.38M
37.23%355.37M
27.28%393.88M
22.72%425.77M
-10.67%212.31M
-3.91%258.96M
7.43%309.46M
76.13%346.95M
3.85%237.68M
8.35%269.51M
Total current liabilities
-4.53%63.60M
20.90%73.44M
58.31%83.07M
66.61%68.15M
51.45%66.61M
35.78%60.74M
39.78%52.47M
-0.39%40.90M
10.97%43.98M
-3.51%44.74M
-3.29%37.54M
15.62%41.06M
37.44%39.64M
62.40%46.37M
12.31%38.82M
26.00%35.52M
-5.75%28.84M
-15.11%28.55M
12.18%34.56M
3.37%28.19M
Total assets
-29.38%527.07M
-24.74%589.07M
-20.01%661.95M
-15.54%720.98M
-17.21%746.34M
108.51%782.73M
103.77%827.49M
89.28%853.62M
95.98%901.44M
-23.43%375.38M
53.92%406.10M
43.64%450.99M
26.37%459.97M
20.89%490.27M
-11.06%263.83M
-5.04%313.98M
4.07%363.99M
37.83%405.56M
-6.45%296.64M
6.47%330.65M
Total liabilities
11.46%418.24M
15.63%410.94M
13.11%396.50M
14.96%374.52M
17.48%375.23M
34.67%355.40M
55.39%350.52M
46.97%325.78M
65.45%319.41M
37.74%263.91M
119.70%225.58M
122.87%221.66M
107.91%193.05M
107.72%191.60M
97.81%102.68M
111.73%99.45M
85.04%92.85M
9.54%92.24M
-35.33%51.91M
-8.96%46.97M
Total equity
-70.68%108.83M
-58.32%178.13M
-44.35%265.45M
-34.36%346.46M
-36.24%371.11M
283.34%427.32M
164.22%476.96M
130.16%527.84M
118.05%582.03M
-62.68%111.47M
12.02%180.52M
6.91%229.34M
-1.56%266.92M
-4.67%298.67M
-34.15%161.15M
-24.38%214.52M
-9.49%271.14M
49.18%313.32M
3.34%244.73M
9.55%283.68M
Cash Flow Statement
Net operating income
13.56%-65.32M
-77.47%-67.32M
11.52%-67.90M
-42.48%-72.78M
-86.52%-75.56M
-52.76%-37.93M
-90.95%-76.74M
-33.91%-51.08M
4.49%-40.51M
-70.49%-24.83M
-25.97%-40.19M
-23.82%-38.15M
-21.09%-42.42M
-59.05%-14.57M
8.19%-31.90M
15.85%-30.81M
6.19%-35.03M
66.97%-9.16M
11.04%-34.75M
-35.93%-36.61M
Net investment
261.47%96.15M
122.56%86.54M
470.71%35.55M
11504.88%95.92M
-11072.05%-59.55M
-25870.82%-383.59M
-540.12%-9.59M
80.84%-841.00K
85.28%-533.00K
-133.33%-1.48M
77.96%-1.50M
-66.25%-4.39M
-369.78%-3.62M
60.06%-633.00K
-76.04%-6.80M
-74.72%-2.64M
59.42%-771.00K
71.03%-1.58M
4.64%-3.86M
40.11%-1.51M
Net financing
---2.06M
-105.99%-1.80M
-1058.92%-1.77M
63.06%-768.00K
-100.00%0.00
130365.22%30.01M
4525.00%185.00K
-849.32%-2.08M
81350.51%561.44M
-99.99%23.00K
-96.08%4.00K
---219.00K
-69000.00%-691.00K
51.62%223.51M
144.35%102.00K
-100.00%0.00
-100.00%-1.00K
37505.87%147.41M
-2400.00%-230.00K
4663.64%13.55M

FAQs

What is the total revenue of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its total revenue reached 75.39M, with a year-on-year change of 10.12M.

What are the current assets of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its current assets were 435.92M, with a year-on-year change of -34.05.

What are the total assets of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its total assets of Autolus Therapeutics PLC were 589.07M, with a year-on-year change of -24.74.

What are the total liabilities of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its total liabilities of Autolus Therapeutics PLC were 410.94M, with a year-on-year change of 15.63.

What is the total equity of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its total equity of Autolus Therapeutics PLC was 178.13M, with a year-on-year change of -58.32.

What is the net operating income of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its net operating income of Autolus Therapeutics PLC was -270.24M, with a year-on-year change of -12.23.

What is the net investment of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its net investment of Autolus Therapeutics PLC was 158.46M, with a year-on-year change of 140.16.

What is the net financing of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its net financing of Autolus Therapeutics PLC was -4.34M, with a year-on-year change of -100.74.

What is the Earnings Per Share (EPS) of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its Earnings Per Share (EPS) was -1.08, with a year-on-year change of -24.93.

What is the net income of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its net income was -287.53M, with a year-on-year change of -30.30.

What is the net margin of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its net profit margin was -381.40, with a year-on-year change of 82.51.

What is the gross margin of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its gross margin was -26.10, with a year-on-year change of -309.46.

What is the debt-to-asset ratio of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its debt-to-asset ratio was 45.87, with a year-on-year change of 46.78.

What is the Return on Equity (ROE) of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its Return on Equity (ROE) was -94.98, with a year-on-year change of -15.96.

What is the Return on Assets (ROA) of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its Return on Assets (ROA) was -41.92, with a year-on-year change of -10.00.

What is the operating profit of Autolus Therapeutics PLC?

According to Autolus Therapeutics PLC's FY2025 earnings report, its operating profit was -270.24M, with a year-on-year change of -12.23.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy